108 related articles for article (PubMed ID: 8624279)
1. Blood transfusion as a risk factor for non-Hodgkin lymphoma.
Brandt L; Brandt J; Olsson H; Anderson H; Möller T
Br J Cancer; 1996 May; 73(9):1148-51. PubMed ID: 8624279
[TBL] [Abstract][Full Text] [Related]
2. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia.
Cerhan JR; Wallace RB; Dick F; Kemp J; Parker AS; Zheng W; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):361-8. PubMed ID: 11319177
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
4. Blood transfusion and non-Hodgkin lymphoma: lack of association.
Adami J; Nyrén O; Bergström R; Ekbom A; McLaughlin JK; Högman C; Fraumeni JF; Glimelius B
Ann Intern Med; 1997 Sep; 127(5):365-71. PubMed ID: 9273827
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukaemias and non-Hodgkin's lymphomas by histological type in farming-animal breeding workers: a population case-control study based on job titles.
Amadori D; Nanni O; Falcini F; Saragoni A; Tison V; Callea A; Scarpi E; Ricci M; Riva N; Buiatti E
Occup Environ Med; 1995 Jun; 52(6):374-9. PubMed ID: 7627313
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet radiation exposure and risk of malignant lymphomas.
Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Feb; 97(3):199-209. PubMed ID: 15687363
[TBL] [Abstract][Full Text] [Related]
7. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
8. Chronic lymphocytic leukaemias and non-Hodgkin's lymphomas by histological type in farming-animal breeding workers: a population case-control study based on a priori exposure matrices.
Nanni O; Amadori D; Lugaresi C; Falcini F; Scarpi E; Saragoni A; Buiatti E
Occup Environ Med; 1996 Oct; 53(10):652-7. PubMed ID: 8943828
[TBL] [Abstract][Full Text] [Related]
9. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
10. Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.
Cerhan JR; Engels EA; Cozen W; Davis S; Severson RK; Morton LM; Gridley G; Hartge P; Linet M
Int J Cancer; 2008 Aug; 123(4):888-94. PubMed ID: 18506687
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
12. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
[TBL] [Abstract][Full Text] [Related]
13. Gender and time differences in initial location and histological grade of non-Hodgkin's lymphomas in Southern Sweden.
Brandt L; Brandt J; Olsson H; Anderson H; Möller T
Acta Oncol; 2001; 40(4):479-84. PubMed ID: 11504307
[TBL] [Abstract][Full Text] [Related]
14. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium.
't Mannetje A; De Roos AJ; Boffetta P; Vermeulen R; Benke G; Fritschi L; Brennan P; Foretova L; Maynadié M; Becker N; Nieters A; Staines A; Campagna M; Chiu B; Clavel J; de Sanjose S; Hartge P; Holly EA; Bracci P; Linet MS; Monnereau A; Orsi L; Purdue MP; Rothman N; Lan Q; Kane E; Costantini AS; Miligi L; Spinelli JJ; Zheng T; Cocco P; Kricker A
Environ Health Perspect; 2016 Apr; 124(4):396-405. PubMed ID: 26340796
[TBL] [Abstract][Full Text] [Related]
15. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples.
Goldin LR; Landgren O; McMaster ML; Gridley G; Hemminki K; Li X; Mellemkjaer L; Olsen JH; Linet MS
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2402-6. PubMed ID: 16214923
[TBL] [Abstract][Full Text] [Related]
16. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
[TBL] [Abstract][Full Text] [Related]
17. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin lymphoma in Romania: a single-centre experience.
Fetica B; Achimas-Cadariu P; Pop B; Dima D; Petrov L; Perry AM; Nathwani BN; Müller-Hermelink HK; Diebold J; MacLennan KA; Fulop A; Blaga ML; Coza D; Nicula FA; Irimie A; Weisenburger DD
Hematol Oncol; 2017 Jun; 35(2):198-205. PubMed ID: 26482423
[TBL] [Abstract][Full Text] [Related]
19. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C infection and risk of malignant lymphoma.
Schöllkopf C; Smedby KE; Hjalgrim H; Rostgaard K; Panum I; Vinner L; Chang ET; Glimelius B; Porwit A; Sundström C; Hansen M; Adami HO; Melbye M
Int J Cancer; 2008 Apr; 122(8):1885-90. PubMed ID: 18271005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]